HIGHLIGHTS
- who: Qiyu Tong et al. from the Laboratory of Biotherapy and Cancer Center, West China, University and Collaborative have published the article: Targeting RNA G-quadruplex with repurposed drugs blocks SARS-CoV-2 entry, in the Journal: (JOURNAL) of January/26,/2023
- what: The authors report the potential of RNA G-quadruplex (RG4)-targeting therapeutic strategy for SARS-CoV-2 entry. Combining bioinformatics biochemical and biophysical approaches the authors characterize the existence of RG4s in several SARS-CoV-2 host factors. Given that drug repurposing has been extensively used to meet the unmet need for . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.